PZ Cormay Past Earnings Performance
Past criteria checks 0/6
PZ Cormay's earnings have been declining at an average annual rate of -28.4%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 4.6% per year.
Key information
-28.4%
Earnings growth rate
-27.3%
EPS growth rate
Medical Equipment Industry Growth | 25.3% |
Revenue growth rate | -4.6% |
Return on equity | -8.5% |
Net Margin | -5.7% |
Last Earnings Update | 30 Sep 2023 |
Revenue & Expenses Breakdown
How PZ Cormay makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 23 | 84 | -5 | 35 | 4 |
30 Jun 23 | 87 | -1 | 36 | 4 |
31 Mar 23 | 85 | -3 | 36 | 4 |
31 Dec 22 | 85 | -7 | 35 | 3 |
30 Sep 22 | 88 | -4 | 34 | 4 |
30 Jun 22 | 87 | -7 | 34 | 4 |
31 Mar 22 | 86 | -2 | 32 | 3 |
31 Dec 21 | 85 | 2 | 31 | 3 |
30 Sep 21 | 81 | -4 | 30 | 2 |
30 Jun 21 | 75 | -3 | 29 | 1 |
31 Mar 21 | 68 | -4 | 28 | 1 |
31 Dec 20 | 65 | -13 | 29 | 0 |
30 Sep 20 | 63 | -46 | 31 | 0 |
30 Jun 20 | 67 | -46 | 32 | 0 |
31 Mar 20 | 69 | -50 | 33 | 0 |
31 Dec 19 | 68 | -41 | 33 | 0 |
30 Sep 19 | 70 | -27 | 32 | 0 |
30 Jun 19 | 66 | -25 | 32 | 0 |
31 Mar 19 | 68 | -22 | 33 | 0 |
31 Dec 18 | 70 | -25 | 33 | 0 |
30 Sep 18 | 71 | -1 | 33 | 0 |
30 Jun 18 | 71 | -1 | 33 | 0 |
31 Mar 18 | 74 | -1 | 34 | 0 |
31 Dec 17 | 78 | -2 | 35 | 0 |
30 Sep 17 | 76 | -13 | 36 | 0 |
30 Jun 17 | 79 | -14 | 36 | 0 |
31 Mar 17 | 81 | -13 | 36 | 0 |
31 Dec 16 | 82 | -11 | 36 | 0 |
30 Sep 16 | 75 | -3 | 32 | 0 |
30 Jun 16 | 68 | -3 | 27 | 0 |
31 Mar 16 | 55 | -7 | 25 | 0 |
31 Dec 15 | 45 | -25 | 20 | 0 |
30 Sep 15 | 57 | -56 | 30 | 0 |
30 Jun 15 | 67 | -55 | 36 | 2 |
31 Mar 15 | 84 | -60 | 40 | 2 |
31 Dec 14 | 99 | -42 | 46 | 2 |
30 Sep 14 | 104 | -10 | 39 | 7 |
30 Jun 14 | 104 | -9 | 37 | 6 |
31 Mar 14 | 102 | 1 | 34 | 5 |
31 Dec 13 | 101 | 2 | 35 | 5 |
Quality Earnings: CRM is currently unprofitable.
Growing Profit Margin: CRM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CRM's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare CRM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CRM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Return on Equity
High ROE: CRM has a negative Return on Equity (-8.48%), as it is currently unprofitable.